Gilgamesh Pharmaceuticals

AbbVie joins psychedelic push, inks $2B+ next-gen neuro deal with Gilgamesh
Fierce Biotech
Mon, 05/13/24 - 10:21 pm
AbbVie
psychedelics
Gilgamesh Pharmaceuticals
R&D
Gilgamesh starts subject dosing in major depressive disorder trial
Clinical Trials Arena
Thu, 05/2/24 - 11:25 am
Gilgamesh Pharmaceuticals
clinical trials
GM-1020
major depressive disorder